The physician was not rebuked because the patient was treated according to guidelines
Check your specific plans formulary before assuming coverage
Metallomics 7 (2), 232243
Wegovy is FDA-approved for chronic weight management in adults and pediatric patients aged 12 years and older with obesity (BMI 30 kg/m for adults, 95th percentile for age and sex in pediatrics) or overweight (BMI 27 kg/m for adults, 85th percentile for pediatrics) with at least one weight-related comorbidity
Through Noom Med, you can get access to GLP-1s like Wegovy, Ozempic, Metformin, Zepbound, Mounjaro, and generic Liraglutide
To qualify for Mounjaro, a person must have type 2 diabetes or have overweight or obesity with another weight-related condition, such as high blood pressure